Advanced Medical Solutions filings show Investec trading and Octopus 8.97% stake
Rule 8 Takeover Code disclosures dated July 7 show Investec Bank plc trading as adviser and joint broker, while Octopus Investments Ltd reported a 19.8 million-share holding and small disposals as of July 6.
Advanced Medical Solutions Group plc was the subject of separate U.K. Takeover Code disclosures dated 07 July 2026 covering positions and dealings on 06 July 2026. Investec Bank plc, acting as an exempt principal trader in a client-serving capacity and connected to the company as adviser and joint broker, reported buying 589,782 ordinary shares at 279.5p to 280.25p and selling 664,705 shares at 280p to 281p under Rule 8.5. Separately, Octopus Investments Ltd filed a Rule 8.3 opening position/dealing disclosure showing ownership or control of 19,803,905 ordinary 5p shares, equal to 8.97% of the class, and reported selling 32,870 shares at 2.8025 per share plus an in-specie transfer out of 2,200 shares. Both filings said there were no derivatives, options, indemnity arrangements or other understandings relating to the shares.
- Rule 8.5 of the Takeover Code: UK takeover disclosure rule requiring certain intermediaries, including exempt principal traders, to report dealings during an offer period
- Rule 8.3 of the Takeover Code: U.K. disclosure rule requiring investors with interests of 1% or more in relevant securities to report positions and dealings during an offer period
- in-specie transfer out: Transfer of securities without a cash sale